Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: PFIZER INC
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2021-11-17 to 2023-01-31
Current total value of award: $12549999847.5
Description: COVID-19 ACTION      ORAL PROTEASE INHIBITOR PF-07321332 (PAXLOVID)